---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-014622"
form_type: "8-K"
ticker: "MBOT"
cik: "0000883975"
company_name: "Microbot Medical Inc."
filed_at: "2025-06-11T23:59:59+00:00"
generated_at: "2026-05-19T14:47:08.839849+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Microbot Medical shareholders approve increase in authorized common shares to 120M; Series I options become exercisable

## Summary
- Authorized common shares increased from 61M to 120M; total authorized shares now 121M (including 1M preferred).
- Stockholders approved issuance of Series I options (12,206,578 shares at $2.13) and placement agent options (305,164 shares at $2.6625); now immediately exercisable.
- Amendment to 2020 Omnibus Performance Award Plan approved, adding 2,591,019 authorized shares.
- Class I directors elected: Harel Gadot, Martin Madden, Tal Wenderow; each received >3M votes for.
- Brightman Almagor Zohar & Co. ratified as independent auditor for FY2025 with 13.2M votes in favor.

## SEC filing metadata
- accession: 0001641172-25-014622
- form_type: 8-K
- ticker: MBOT
- cik: 0000883975
- company_name: Microbot Medical Inc.
- filed_at: 2025-06-11T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 3.03, 5.03, 5.07, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/883975/000164117225014622/0001641172-25-014622-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/883975/000164117225014622/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-014622
- JSON: https://secwatch.observer/filing/0001641172-25-014622.json
- Plain text: https://secwatch.observer/filing/0001641172-25-014622.txt

## Key facts
- Governance Changes
  Microbot Medical Inc.: Increased authorized common stock from 61,000,000 to 120,000,000 shares, and total authorized shares from 61,000,000 to 121,000,000 shares (effective 2025-06-10).
  - Change: charter amendment
  - Effective: 2025-06-10
  source text: On June 10, 2025 (the “Effective Time”), in keeping with stockholder approval obtained at the 2025 Annual Meeting of Stockholders (the “Annual Meeting”) of Microbot Medical Inc. (the “Company”), discussed further below in this Current Report on Form 8-K, the Company filed with the State of Delaware a Certificate of Amendment to the Company’s Restated Certificate of Incorporation, as amended, which increased the total number of shares of common stock, par value $0.01 per share (the “Common Stock”) authorized for issuance to 120,000,000 shares, with a corresponding increase in the total authorized shares from 61,000,000 to 121,000,000.
  evidence_url: https://www.sec.gov/Archives/edgar/data/883975/000164117225014622/0001641172-25-014622-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.